Main content

    Renal and Urinary Tract Cancer Clinical Trials

    CPMC Cancer ServicesOpens new window

    Oncology / Cancer Clinical Trials Main Page | Adult Clinical Trials Main Page

    Further protocol information can be found on the links below at

    Active Trials

    Title: A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab Versus Placebo in Subjects With High Risk Invasive Urothelial Carcinoma (CheckMate 274: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 274)
    Description: The purpose of this study is to determine the efficacy and safety of nivolumab versus placebo in participants who have undergone radical surgery for invasive urothelial cancer
    Investigator: Ari Baron, MD
    Eligibility: Subjects 18 y/o and older with invasive urothelial cancer at high risk of recurrence originating in the bladder, ureter, or renal pelvis; must have had radical surgical resection (e.g. radical cystectomy), performed within the last 90 days; must have disease free status as determined by imaging within 4 weeks of dosing
    Status: Active and open to enrollment
    Contact: Madeline Decker, 415-600-3613, Email: about Study BMS CA209-274

    Title: A Prospective Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery for Patients With High Grade Upper Tract Urothelial Carcinoma
    Description: This phase II trial studies how well giving chemotherapy before surgery works in treating patients with aggressive upper urinary tract cancer
    Investigators: NCI - National Cancer Institute
    Eligibility: Subjects, 18 y/o and older, who have
    Status: Please contact site for study status
    Contact: Madeline Decker, 415-600-3613, Email: about Study EA8141

    • updated November 2016

    Back to top